Nestor Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1975.
1975 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Nestor Pharmaceuticals Limited

Nestor Pharmaceuticals Limited, a active public limited company, was established on 13 October 1975 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1975PLC007959. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹43.18 Cr.

It upholds a compliant status. Employing 567 professional, Its leadership includes Adarsh Pal Singh (Director), Bhanu Prakash Tiwari (Director), Rahul Sehgal (Director). Past directors included Saudagar Saini, Rajiv Bedi, Adarsh Pal Singh. It holds ₹98.66 Cr open charges and ₹156.76 Cr settled loans. Its latest AGM occurred on 09 June 2025, with the balance sheet filed on 31 March 2025. It is based at A-106, Dda Shed, Phase-Ii, Okhla Industrial Area, New Delhi, Delhi, 110020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL1975PLC007959

  • Registration Number

    007959

  • Incorporation Date

    13 October 1975

  • Authorized Capital

    ₹50.00 Cr

  • Paid-Up Capital

    ₹43.18 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 Cr
  • Paid Up Capital ₹ 43.18 Cr
  • Company Age 50 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 98.66 Cr
  • Satisfied Charges ₹ 156.76 Cr
  • Revenue Growth **** 8.22%
  • Profit Growth **** -16.64%
  • Ebitda **** 5.27%
  • Net Worth 10.78%
  • Total Assets **** 16.41%
Company report

Nestor Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nestor Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nestor Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Adarsh Pal Singh Director 25 May 2021 Current
Bhanu Prakash Tiwari Director 18 Mar 2019 Current
Rahul Sehgal Director 25 May 2018 Current
Bhisham Singh Director 20 Feb 2023 Current
Bharat Ram Director 25 Jan 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 31 Mar 2011 Past
Pramod Abcsdd Director 10 Nov 2011 Past
Pramod Abcsdd Additional Director 28 Jul 2021 Past
Pramod Abcsdd Manager - Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Manager - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nestor Pharmaceuticals.

Nestor Pharmaceuticals Limited, for the financial year ended 2025, experienced modest growth in revenue, with a 8.22% increase. The company also saw a substantial fall in profitability, with a 16.64% decrease in profit. The company's net worth Soared by an impressive increase of 10.78%.

Nestor Pharmaceuticals revenue growth over time
Nestor Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.22%
*******
*******
*******
*******
Revenue from Operations
*******
 8.20%
*******
*******
*******
*******
Total Assets
*******
 16.41%
*******
*******
*******
*******
Profit or Loss
*******
 -16.64%
*******
*******
*******
*******
Net Worth
*******
 10.78%
*******
*******
*******
*******
EBITDA
*******
 5.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nestor Pharmaceuticals?

In 2024, Nestor Pharmaceuticals had a promoter holding of 90.18% and a public holding of 9.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹986,600,000.00

Satisfied Charges

₹1,567,582,993.00

Charges Breakdown by Lending Institutions
  • Others : 98.66 Cr
Latest Charge Details
Date Lender Amount Status
30 Dec 2021 Others ₹2.84 Cr Open
09 Dec 2021 Others ₹2.15 Cr Open
15 Jan 2021 Others ₹9.87 Cr Open
10 Nov 2010 Others ₹36.56 Cr Open
08 Jan 2009 Others ₹47.24 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Nestor Pharmaceuticals?

Nestor Pharmaceuticals has a workforce of 567 employees as of Nov 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nestor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nestor Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nestor Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Nestor Pharmaceuticals Limited last Annual general meeting of members was held on 09 Jun 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 36.56 Cr registered on 10 Nov 2010 with Charge ID 10254197 was modified on 24 Apr 2025. was completed.

  • Director Appointment

    Progress on Neha Joshi was appointed as a Company Secretary was appointed as a Company Secretary on 12 Apr 2025 & has been associated with this company since 10 months 5 days . was documented.

  • Balance Sheet

    Nestor Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 2.15 Cr registered on 09 Dec 2021 with Charge ID 100512486 was modified on 15 Mar 2023. was recorded as a recent event.

  • Director Appointment

    Progress on Bhisham Singh was appointed as a Director was appointed as a Director on 20 Feb 2023 & has been associated with this company since 2 years 11 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nestor Pharmaceuticals Limited?

The CIN of Nestor Pharmaceuticals Limited is U24231DL1975PLC007959.

Where is Nestor Pharmaceuticals Limited headquartered?

Nestor Pharmaceuticals Limited is headquartered at A-106, Dda Shed, Phase-Ii, Okhla Industrial Area, New Delhi, Delhi, 110020.

When was Nestor Pharmaceuticals Limited incorporated?

Nestor Pharmaceuticals Limited was incorporated on 13 October 1975.

Who are the current directors of Nestor Pharmaceuticals Limited?

The current directors of Nestor Pharmaceuticals Limited are

What is the primary industry of Nestor Pharmaceuticals Limited?

The primary industry of Nestor Pharmaceuticals Limited is Manufacturing.

Is Nestor Pharmaceuticals Limited a listed company?

Nestor Pharmaceuticals Limited is unlisted.

What is the capital structure of Nestor Pharmaceuticals Limited?

The authorized capital of Nestor Pharmaceuticals Limited is ₹50.00 Cr, and the paid-up capital is ₹43.18 Cr.

What is the compliance status of Nestor Pharmaceuticals Limited?

The compliance status of Nestor Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available